Alternative performance measures
In this report, Corbion has included certain non-IFRS financial information. This information is presented to assist in making appropriate comparisons with prior periods, and Corbion uses these measures to assess the operating performance of the business, include them in bonus targets and believes that the information is useful to users of the financial information. The non-IFRS financial measures do not have a standardized meaning prescribed by the IASB, and therefore may not be comparable to similar measures presented by other issuers.
Corbion believes the APMs are relevant based on the following considerations.
APM category |
Relevance |
---|---|
EBITDA |
Corbion believes the measure provides valuable insight in the understanding of operating profitability and the cash flow component thereof. Further, it is a common APM used by other companies, therefore providing better comparability of Corbion's performance to other companies. |
Adjustments, Adjusted EBITDA, Adjusted operating result, Adjusted result after taxes, Adjusted EBITDA margin% |
Adjustments and the related adjusted APMs show items that in view of management require disclosure to assist in making appropriate comparisons with prior periods and to assess the underlying operating performance of the business as it excludes sizeable items of an incidental/one-off nature. |
Organic EBITDA growth, Organic sales growth, Organic operating profit growth, Adjusted EBITDA excluding acquisitions and divestments, at constant currencies |
The organic growth measures are used to explain the underlying result development of the business by separate disclosing, and thus excluding, the impacts from currencies and acquisitions and divestments. It thus provides a better basis for comparison and assessment of business performance without distortion from these external sources. |
Covenant EBITDA, Interest cover, Covenant net debt position, Total net debt position |
Corbion believes these measures are important as the existing debt providers to the Company (RCF and USPP lenders) require these measures to be used in the external loan documentation. |
ROCE, Capital employed, Average capital employed |
ROCE and the related APMs are relevant measures analyzing profitability and for comparing profitability levels across companies in terms of capital sizes and returns therefrom. Further, these are widely used APM’s by other companies, and therefore are providing better comparability of Corbion’s performance to other companies. |
Free cash flow |
This measure provides insight into the cash flows available for debt reduction and dividend payments. Free cash flow should not be read as an alternative to, for example, operating cash flow. |
The table below gives an overview of the alternative performance measures used and their definitions.
APM |
Definition |
---|---|
EBITDA |
The operating result before depreciation, amortization, and (reversal of) impairment of (in)tangible fixed assets. |
Adjusted EBITDA |
EBITDA as defined above after applying adjustments. |
Adjusted EBITDA margin % |
Adjusted EBITDA as defined above divided by net sales x 100. |
Adjusted EBITDA excluding acquisitions and divestments, at constant currencies |
Adjusted EBITDA as defined above excluding the impact of acquisitions and divestments, based on prior-year currency rates. |
Covenant EBITDA |
Adjusted EBITDA as defined above increased by cash dividend of joint ventures received and annualization effect of newly acquired and/or divested subsidiaries. |
Organic EBITDA growth |
Adjusted EBITDA as defined above versus prior year excluding impact of acquisitions and divestments and excluding currency impact. |
Organic sales growth |
Sales versus prior year excluding impact of acquisitions and divestments and excluding currency impact. |
Adjusted operating result |
Operating result after adjustments. |
Adjusted result after taxes |
Result after taxes after adjustments. |
Interest cover |
Covenant EBITDA as defined above divided by net interest income and charges. |
Covenant net debt position |
Borrowings (excluding subordinated loans) and lease liabilities less cash and cash equivalents, including third-party guarantees which are required to be included under the debt covenants. |
Total net debt position |
Borrowings and lease liabilities less cash and cash equivalents, including third-party guarantees which are required to be included under the debt covenants. |
Capital employed |
The sum of equity, borrowings, lease liabilities, and other non-current liabilities minus cash and cash equivalents. |
Average capital employed |
Average of the quarterly average capital employed in the reporting period. |
Free cash flow |
Cash flow from operating activities plus cash flow from investment activities. |
Return on capital employed (ROCE) |
Adjusted operating profit as defined above, including adjusted operating profit from joint ventures and associates, divided by the average capital employed x 100. |
Adjustments |
Adjustments relate to significant items in the income statement of such size, nature or incidence that in view of management require disclosure to assist in making appropriate comparisons with prior periods and to assess the operating performance of the business. These items include amongst others write-down of inventories to net realizable value, reversals of write-downs, impairments, reversals of impairments, additions to and releases from provisions for restructuring and reorganization, results on assets sold, gains on the sale of subsidiaries, joint ventures and associates, and any other provision being formed or released. Restructuring costs are defined as the estimated costs of initiated reorganizations, which have been approved by the Executive Committee, and which generally involve the realignment of certain parts of the organization. The company only adjusts for items when the aggregate amount of the events per line item of the income statement exceeds a yearly threshold of € 0.5 million as well as adjustments, each above € 0.1 million, in relation to previously recognized adjustments. |
The table below gives a selection of the APMs used versus the most directly comparable IFRS measure.
€ million |
2024 |
2023 |
---|---|---|
The following APMs have been reported based on continued operations |
||
Operating result |
77.3 |
77.3 |
Depreciation, amortization, and impairments |
87.0 |
55.8 |
EBITDA |
164.3 |
133.1 |
Adjustments to EBITDA |
||
- Remeasurement contingent purchase price SB Renewable Oils |
-0.8 |
5.2 |
- Restructuring costs |
9.4 |
0.6 |
- Inefficiencies at start-up at our new lactic acid facility in Thailand |
1.0 |
|
- Legal cases |
0.6 |
|
- Planned settlement of defined benefit schemes |
0.5 |
0.4 |
- Acquisition costs |
0.5 |
|
- Reversal of accruals presented as adjustments in previous periods |
-0.8 |
|
- Exceptional write down of a receivable |
0.6 |
|
- Environmental fine in one of our production sites |
0.6 |
|
Total adjustments to EBITDA |
10.7 |
7.1 |
Adjusted EBITDA |
175.0 |
140.2 |
Adjusted EBITDA (A) |
175.0 |
140.2 |
Net sales (B) |
1,288.1 |
1,264.1 |
Adjusted EBITDA margin (A/B) |
13.6% |
11.1% |
Operating result |
77.3 |
77.3 |
Adjustments to operating result |
||
- Adjustments to EBITDA |
10.7 |
7.1 |
- (Reversal of) impairments and incidental accelerated depreciation |
2.7 |
-21.7 |
Total adjustments to operating result |
13.4 |
-14.6 |
Adjusted operating result |
90.7 |
62.7 |
Net result |
45.9 |
43.1 |
Adjustments to result after taxes |
||
- Total adjustments to operating result |
13.4 |
-14.6 |
- Impairment in our PLA joint venture |
6.8 |
|
- Tax effects on adjustments |
-2.9 |
-0.4 |
Total adjustments to result after taxes |
10.5 |
-8.2 |
Adjusted result after taxes |
56.4 |
34.9 |
Adjusted EBITDA |
175.0 |
140.2 |
Impact acquisitions and divestments |
-4.5 |
|
Currency impact |
2.4 |
10.3 |
Adjusted EBITDA excluding acquisitions and divestments, at constant currencies |
172.9 |
150.5 |
Adjusted EBITDA prior year (A) |
140.2 |
125.3 |
Adjusted EBITDA excluding acquisitions and divestments, at constant currencies current year (B) |
172.9 |
150.5 |
Organic adjusted EBITDA growth ((B-A)/A)*100% |
23.3% |
20.1% |
Sales |
1,288.1 |
1,264.1 |
Impact acquisitions and divestments |
-4.5 |
|
Currency impact |
8.5 |
27.3 |
Sales excluding acquisitions and divestments, at constant currencies |
1,292.1 |
1,291.4 |
Sales prior year (A) |
1,264.1 |
1,254.3 |
Sales excluding acquisitions and divestments, at constant currencies current year (B) |
1,292.1 |
1,291.4 |
Organic Sales growth ((B-A)/A)*100% |
2.2% |
3.0% |
Operating profit |
77.3 |
77.3 |
Impact acquisitions and divestments |
-4.5 |
9.6 |
Currency impact |
1.1 |
5.7 |
Operating profit excluding acquisitions and divestments, at constant currencies |
73.9 |
92.6 |
Operating profit prior year (A) |
77.3 |
58.8 |
Operating profit excluding acquisitions and divestments, at constant currencies current year (B) |
73.9 |
92.6 |
Organic Operating profit growth ((B-A)/A)*100% |
-4.4% |
57.5% |
The following APMs have been reported based on total operations |
||
Cash flow from operating activities |
184.1 |
165.4 |
Cash flow from investment activities |
166.0 |
-146.8 |
Free cash flow |
350.1 |
18.6 |
Equity |
772.5 |
636.2 |
Borrowings |
450.2 |
720.6 |
Lease liabilities |
59.0 |
64.9 |
Other non-current liabilities |
3.9 |
13.3 |
-/- Cash and cash equivalents |
-49.3 |
-70.2 |
Capital employed 31/12 |
1,236.3 |
1,364.8 |
Capital employed end Q4 prior year (A) |
1,364.8 |
1,342.5 |
Capital employed end Q1 (B) |
1,399.2 |
1,411.3 |
Capital employed end Q2 (C) |
1,224.2 |
1,404.7 |
Capital employed end Q3 (D) |
1,242.2 |
1,439.2 |
Capital employed end Q4 current year (E) |
1,236.3 |
1,364.8 |
Average capital employed for the year ((A+B)/2+(B+C)/2+(C+D)/2+(D+E)/2)/4) |
1,291.5 |
1,402.2 |
Adjusted operating result |
102.7 |
107.2 |
Adjusted operating result from joint ventures and associates |
1.6 |
6.5 |
Adjusted operating result basis for ROCE (A) |
104.3 |
113.7 |
Average capital employed for the year (B) |
1,291.5 |
1,402.2 |
Return on capital employed (A/B) |
8.1% |
8.1% |
Borrowings |
450.2 |
720.6 |
Lease liabilities |
59.0 |
64.9 |
-/- Cash and cash equivalents |
-49.3 |
-70.2 |
Total net debt position |
459.9 |
715.3 |
Borrowings |
450.2 |
720.6 |
Lease liabilities |
59.0 |
64.9 |
-/- Subordinated loan |
-99.7 |
-99.6 |
-/- Cash and cash equivalents |
-49.3 |
-70.2 |
Covenant net debt position |
360.2 |
615.7 |
Adjusted EBITDA including discontinued operations |
187.7 |
191.8 |
Impact sold business |
-12.7 |
|
Cash dividend of joint ventures and associates |
0 |
4.6 |
Covenant EBITDA |
175.0 |
196.4 |
Covenant net debt position (A) |
360.2 |
615.7 |
Covenant EBITDA (B) |
175.0 |
196.4 |
Covenant net debt position/covenant EBITDA (A/B) |
2.1 |
3.1 |
Interest income (Note 7 consolidated financial statements) |
-5.8 |
-6.4 |
Interest expenses (Note 7 consolidated financial statements) |
18.9 |
28.7 |
Interest expense on lease liabilities (Note 7 consolidated financial statements) |
2.4 |
2.5 |
Net interest financial income and charges |
15.5 |
24.8 |
Covenant EBITDA (A) |
175.0 |
196.4 |
Net interest financial income and charges (B) |
15.5 |
24.8 |
Interest cover (A/B) |
11.3 |
7.9 |
TotalEnergies Corbion bv |
||
Adjusted operating result |
3.1 |
13.0 |
Depreciation, amortization, and impairments |
8.5 |
19.9 |
EBITDA |
11.6 |
32.9 |